Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Immunology|April 6, 2023
Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancerJames Monkman, Honesty Kim, Aaron Mayer, et al.
Kidney International|May 27, 2023
Tolerogenic dendritic cells protect against acute kidney injuryJennifer S Y Li, Harry Robertson, Katie Trinh, et al.
Human Molecular Genetics|March 12, 2013
A patient-derived olfactory stem cell disease model for ataxia-telangiectasiaRomal Stewart, Sergei Kozlov, Nicholas Matigian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2018
Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic ProfileNan Xie, Nicholas Matigian, Tharindu Vithanage, et al.
Peerj|April 5, 2016
A molecular classification of human mesenchymal stromal cellsFlorian Rohart, Elizabeth A Mason, Nicholas Matigian, et al.
Nature Communications|August 16, 2023
Platelet-derived exerkine CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged miceOdette Leiter, David Brici, Stephen J Fletcher, et al.
Molecular Oncology|November 17, 2019
Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation loadSandra Pavey, Alex Pinder, Winnie Fernando, et al.
Plos One|July 13, 2011
NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's diseaseAnthony L Cook, Alejandra M Vitale, Sugandha Ravishankar, et al.
Veterinary and Comparative Oncology|August 24, 2019
Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcomaLiliana Endo-Munoz, Tristram C Bennett, Eleni Topkas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune InfiltrationJoshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Pageof 3